Key result
Routine postoperative blood tests after primary total joint replacement rarely led to intervention, with only 19 patients requiring a blood transfusion, 36 requiring sodium treatment, and 18 requiring potassium treatment.
Why the study?
Despite routine postoperative blood testing after total joint replacement, improvements in perioperative care and reduced lengths of stay prompted reconsideration of whether testing is necessary for all patients.
Are routine postoperative blood tests necessary for all patients undergoing primary unilateral total joint replacement?
Observational (n=1,402)
No
Are routine postoperative blood tests necessary for all patients undergoing primary unilateral total joint replacement?
Routine postoperative blood tests after primary total joint replacement are unnecessary for most patients and should be reserved for those with identifiable risk factors.
Challenges routine postoperative blood tests after TJR; leaves open selective testing in modern day-case pathways.
Aims: It is common practice for patients to have postoperative blood tests after total joint replacement (TJR). However, there have been significant improvements in perioperative care with arthroplasty surgery, and a drive to reduce the length of stay (LOS) and move towards day-case TJR. We should reconsider whether this intervention is necessary for all patients. Methods: This retrospective study included all patients who underwent a primary unilateral TJR at a single tertiary arthroplasty centre during a one-year period. Electronic medical records of 1,402 patients were reviewed for patient demographics, LOS, and American Society of Anesthesiologists (ASA) grade. Blood tests were examined to investigate the incidence of postoperative anaemia, electrolyte abnormalities, and incidence of acute kidney injury (AKI). Results: = 0.2) levels were both negatively correlated with LOS (p < 0.001). For all patients who had undergone a TJR, 19 patients (0.014%) required a blood transfusion postoperatively due to symptomatic anaemia. Risk factors identified were age, preoperative anaemia, and long-term aspirin use. Significant abnormal sodium levels were found in123 patients (8.7%). However, only 36 patients (2.6%) required intervening treatment. Risk factors identified were age, preoperative abnormal sodium level, and long-term use of non-steroidal anti-inflammatory drugs, angiotensin receptor blockers, and corticosteroids. Similarly, abnormal potassium levels were evident in 53 patients (3.8%), and only 18 patients (1.3%) required intervening treatment. Risk factors identified were preoperative abnormal potassium level, and long-term use of angiotensin-converting enzyme inhibitors and diuretics. The incidence of AKI was 4.4% (61 patients). Risk factors identified were age, increased ASA grade, preoperative abnormal sodium, and creatinine level. Conclusion: Routine blood tests after primary TJR is unnecessary for most patients. Blood tests should only be performed on those with identifiable risk factors such as preoperative anaemia and electrolyte abnormalities, haematological conditions, long-term aspirin use, and electrolyte-altering medications.
No takes yet. Share an insight, caveat, or question.
Naathan et al. (2023) conducted an observational in Primary unilateral total hip or knee arthroplasty (n=1,402). Routine postoperative blood tests was evaluated on Requirement for intervening treatment based on postoperative blood test abnormalities. Routine postoperative blood tests after primary total joint replacement rarely led to intervention, with only 19 patients requiring a blood transfusion, 36 requiring sodium treatment, and 18 requiring potassium treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: